Phase II clinical trial of S‐1 plus nanoparticle albumin‐bound paclitaxel in untreated patients with metastatic gastric cancer

The present study is the first phase II clinical trial aimed to evaluate the efficacy and safety of S‐1 plus nanoparticle albumin‐bound paclitaxel (Nab‐PTX) as first‐line chemotherapy for advanced gastric cancer (AGC). Previously untreated patients with metastatic gastric adenocarcinoma received S‐1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: He, Ming‐ming, Wang, Feng, Jin, Ying, Yuan, Shu‐qiang, Ren, Chao, Luo, Hui‐yan, Wang, Zhi‐qiang, Qiu, Miao‐zhen, Wang, Zi‐xian, Zeng, Zhao‐lei, Li, Yu‐hong, Wang, Feng‐hua, Zhang, Dong‐sheng, Xu, Rui‐hua
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6215885/
https://ncbi.nlm.nih.gov/pubmed/30281875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13813
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados